ACHR three-lens brief
Evidence-based stock research on ACHR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +3.18% yesterday. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Moved +3.18% yesterday.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $10.06 — 107% above current (9 analysts).
- Negative free cash flow last quarterly (-$415.71M).
- Reported earnings on 2026-11-09.
ACHR closed at $4.86 (+3.18%) as of 2026-11-12. Market cap: $3.80B. Price is above the 50-day MA and below the 200-day MA. Positives: moved +3.18% yesterday.; analyst mean target $10.06 — 107% above current (9 analysts).. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; negative free cash flow last quarterly (-$415.71M).. Last quarter: Revenue $5.10M, net income -$274.50M, free cash flow -$415.71M.
Why three lenses on ACHR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACHR across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ACHR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACHR brief"></iframe>